VP, US Specialty Marketing

About Specialty

Our Specialty business prioritizes research and development (R&D) and commercial investment in healthcare to transform immuno-inflammatory clinical practice and improve patient outcomes. We believe the predictive power of the immune system, human genetics, and advanced technologies such as artificial intelligence provides the greatest opportunity to improve patients’ lives.

Building on decades of research and a long-term commitment to innovative science, Specialty Care focus’ on immuno-inflammation enables us to build portfolios in therapy areas where we can make a difference in patients’ lives and health care practitioner (HCP) practices. Our Specialty portfolio and pipeline represent an opportunity to improve the health of patients now and in the future.

• Benlysta: specifically developed and approved for adult and paediatric lupus. In 2019 the medicine was approved for adults in China. During the year intravenous Benlysta became the first biologic treatment to be approved in the U.S., EU and Japan for children who have limited treatment options for this disease. The company also announced positive results from the pivotal BLISS-LN study showing the effect of Benlysta in active lupus nephritis, an inflammation of the kidneys caused by SLE.
• Nucala: the company’s first-in-class biologic for patients with severe eosinophilic asthma (SEA), continued to strengthen its clinical profile with approval in the U.S. and EU of two new self-administration options, and early data from the REALITI-A study showing Nucala significantly reduces exacerbations in a real-world setting. Approval in the U.S. for use in children with SEA aged six to 11 provided a new option for this difficult to treat patient population.

• Daprodustat: Chronic kidney disease (CKD): Anemia is an important and frequent complication of CKD. However, it is often underdiagnosed and undertreated in patients with early-stage CKD, such as those not on dialysis. When left untreated or undertreated, anemia due to CKD is associated with poor clinical outcomes and leads to a substantial burden on patients and healthcare systems. At GSK, we are dedicated to following the science of anemia and partnering with nephrology experts to better understand the challenges facing patients with anemia of CKD. We are dedicated to developing innovative solutions to meet their needs, help improve their quality of life, and alleviate some of the burden of this condition on patients, caregivers, and the healthcare system.
• Otilimab: the start of the phase III study of its anti GM-CSF antibody, in patients with rheumatoid arthritis, following results from the phase II BAROQUE study.

The US Specialty customer base is unique and complex and includes physicians, ASOCs, DOD, GPOs (national and regional), Physician Supply Houses, and National & Regional Insurers. Given the overlap with Specialty Pharma with US Immunology and Rare Diseases, the customer base has multiple levels and types.

Today, the US Specialty Sales organization consists of 7 second line sales managers (RVPs), 50 First Line Sales Managers (RSDs), and 350 Account Sales Specialists across selling teams, along with other support staff.

The US Specialty Marketing team consists around 30 co-workers led by the VP and 3-4 Sr Directors Marketing.

About the role

Based in Philadelphia or at Research Triangle Park, NC and reporting to SVP, Specialty Business Unit Pharma, the VP Specialty Marketing will provide strategic direction for US Commercial Specialty Business, managing budget and allocating resources to meet or exceed GSK US Sales, profit and strategic goals. 

In this role and together with the VP, US Specialty Sales, you will have accountability for 2 promoted in market blockbuster brands, growing double digits across several Therapeutic Areas: Rheumatology, Allergology, Pulmonology, Nephrology, ENT and 1 asset in launch preparation for next year.

In addition, you will work together with the Global Specialty Product Strategy team for early development assets to align on strategic imperatives forecast, market research and market insight sharing.

• Lead all aspects of the Marketing team and function in the US Specialty Business Unit, from short term operational execution to long term strategic portfolio choices, driving business results & achieving targets.
• Member of the US Specialty Executive team.
• Participation on the Global Specialty Product Strategy Board, and representing Specialty on the US Marketing Leadership Team
• Identify key stakeholders, market segments, and relevant product strategies to drive performance and assure appropriate utilization of

• Benlysta (Systemic Lupus Erythematosus and Lupus Nephritis),
• Nucala in SEA (Severe Eosinophilic Asthma), EGPA (Eosinophilic Granulomatosis with Polyangiitis), NP and HES (hypereosinophilic syndrome)
• Daprodustat: Launch Preparation for first in class HIF (hypoxia-inducible factor) in CKD (chronic kidney disease)

Resilience, adaptability and flexibility are required to achieve success in the rapidly evolving Market, from both clinical and a business perspective.  Multiple levels of affiliations, relationships and decision making across provider and payers will require judgment and sensitivity to conflicting objectives.  Overlap of products and customers requires teamwork and coordination with VP enterprise counterparts as well as relevant market access stakeholders. High degree of matrix working is required.

Key accountabilities

• Leads segmentation of market into meaningful and actionable market sectors. 
• Leads identification of all key stakeholders in the rapidly growing and evolving US Specialty Marketplace.

• Leads development/implementation of all US Specialty marketing/tactical plans
• Develops understanding of all aspects of the Specialty business from a stakeholder (payers, providers, patients, and policy makers) perspective.
• Leads the development of marketing plans, strategies and tactical implementation for Phase III products due to enter the market.
• Leads development and execution of promotional programs which recognize the complex interactions and influences across stakeholders.
• Develops disease awareness, market building and market expansion strategies/programs for GSK US Specialty business.

• Leads allocation and development of all marketing resources to support GSK US Sales Forces in achieving agreed upon sales goals.
• Develops and evaluates innovative marketing strategies to maximize sales/profitability in all segments of the US Specialty market (clinic, hospital, retail)
• Leads development of pricing and contracting strategies to optimize market penetration, market share, and margin performance in relevant reimbursement scenarios across the clinic, hospital and emerging markets.
• Works with relevant internal/external stakeholders to identify and anticipate shifts in Specialty business, market, and reimbursement environment.
• Works with Managed Markets/ contracting to insure access for GSK Specialty products with enterprise customers (i.e. CMS, Medicade, Military, Kaiser, and Managed Care) .
• Identifies current and emerging Specialty key opinion leaders and influencers.
• Develops/enhances key opinion leader relationships (i.e. physician, nurse, policy, patient advocacy, Management Service Orgs/group) to support business objectives.
  Identify, recruit, train and develop key marketing talent in the GSK US Specialty business.
• Actively participates in Specialty cross functional leadership teams (local and global) with Clinical, Regulatory, and Medical Affairs to optimize product profiles through creation of innovative development strategies (launch profiles for new products and new / strengthened indications for in-line products).
• Works with GMS to identify cost effective packaging solutions to meet market needs.
• Develops lifecycle management strategies in order to maximize all of franchise assets.
• Leads external agency relationships for advertising, medical education, and public relations on behalf of the franchise.

Location

RTP, NC or Philadelphia, PA

Candidate profile

Education

• B.S. in Science, Marketing or equivalent required.  MBA or other advanced degree preferred

Experience/knowledge required

• Minimum 10 years pharmaceutical industry experience to include a minimum of 5 years of product management, new product development or business development experience
• Demonstrated success in multiple marketing leadership positions.
• Product launch experience preferred.
• A minimum of 5 years Specialty Pharma Marketing experience
• Demonstrated marketing expertise in all marketing and related activities
• Knowledge of FDA regulation process
• In-depth understanding of the Commercial Interaction with Drug Development Process (discovery, clinical, regulatory)
• Therapeutic area and product knowledge as well as Market Strategy Development

Additional desirable experience and key personal attributes

• Demonstrated ability to successfully influence others in matrix environment.
• Demonstrated ability to lead and develop others
• Ability to inspire leadership and foster teamwork toward a common vision across multiple functional areas
• Demonstrated ability to independently develop and present marketing/tactical plans and strategies to executive management
• Demonstrated ability to manage large assets and launch of new products as well as Rare Disease assets and indications

LI*

Inclusion and diversity at GSK

We believe passionately in inclusion and diversity. Not only is it the right way to do business, but it also leads to business success – unleashing the enormous potential of the differing knowledge, abilities, experiences and styles of our people, and enhancing our ability to respond to the differing needs of our patients and consumers.

Our approach, which is focused on our People, our Business and our Communities, starts inside our company. We’re committed to being more proactive at all levels so that our workforce reflects the communities we serve, and our GSK leadership reflects our GSK workforce.

Therefore, our People focus is on the way we recruit and develop people, exploring ways to foster a more inclusive environment and making sure our policies, processes and support are always fair.

Modern employer

Listening and responding to our people is an important part of being a modern employer. We survey our employees twice a year to understand how they feel about working at GSK and we act on their feedback to help us improve.

We also encourage employees to tell us their views through formal engagement channels and more informal conversations. Our leaders host regular Let’s Talk sessions to encourage people to share their ideas on key topics.

We support informal communication and collaboration across the business through tools such as our collaborative internal tech platform which allows employees to share knowledge and perspectives to support faster decisions across the organization.

Sustainability

GSK strives to operate as a responsible business. In November 2020, we announced ambitious new environmental sustainability goals in both climate and nature, aiming to have a net zero impact on climate and a net positive impact on nature by 2030. The new goals form part of GSK’s Trust priority and ESG (Environmental, Social and Governance) approach, which support the company’s aim to create long-term value for shareholders and meet the needs of society.

Over the next decade, GSK will invest in measures to reduce its environmental impact, in restoration programs to balance the remaining impact that the company cannot reduce and aim to put back into nature more than the company takes out.

Underpinning these goals, the company has set new targets across its different businesses, including 100% renewable electricity usage and good water stewardship at all GSK sites; 100% of materials sustainably sourced and deforestation free; and transitioning to 100% usage of electric vehicles by GSK sales representatives worldwide.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-877-694-7547 (US Toll Free) or 1 801 567 5155 (outside US).

GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

At GSK, the health and safety of our employees are of paramount importance. As a science-led healthcare company on a mission to get ahead of disease together, we believe that supporting vaccination against COVID-19 is the single best thing we can do in the US to ensure the health and safety of our employees, complementary workers, workplaces, customers, consumers, communities, and the patients we serve. 

GSK has made the decision to require all US employees to be fully vaccinated against COVID-19, where allowed by state or local law and where vaccine supply is readily available. The only exceptions to this requirement are employees who are approved for an accommodation for religious, medical or disability-related reasons.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.

Salary : $0